VARIOUS NATIONAL MEDIA: Global trials show drug eases symptoms of chronic cough

Press/Media: Research

Period3 Mar 2022

Media coverage

3

Media coverage

  • TitleHope for chronic cough sufferers with results of global drug trials
    Media name/outletThe Independent
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date3/03/22
    DescriptionPeople who suffer from chronic cough may be offered new hope thanks to a drug that can ease the symptom.

    Researchers suggest the medication called gefapixant has the potential to have a significant impact on the lives of thousands of sufferers.

    Chronic coughing is defined as lasting more than eight weeks, and is thought to affect between 4% and 10% of the UK population, some of whom cough thousands a time a day over many years.
    URLhttps://www.independent.co.uk/news/uk/people-billions-warrington-bbc-itv-b2028266.html
    PersonsJacky Smith
  • TitleHope for chronic cough sufferers with results of global drug trials
    Media name/outletDaily Mail
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date3/03/22
    DescriptionPeople who suffer from chronic cough may be offered new hope thanks to a drug that can ease the symptom.

    Researchers suggest the medication called gefapixant has the potential to have a significant impact on the lives of thousands of sufferers.

    Chronic coughing is defined as lasting more than eight weeks, and is thought to affect between 4% and 10% of the UK population, some of whom cough thousands a time a day over many years.
    URLhttps://www.dailymail.co.uk/wires/pa/article-10575747/Hope-chronic-cough-sufferers-results-global-drug-trials.html
    PersonsJacky Smith
  • TitleHope for chronic cough sufferers with results of global drug trials
    Media name/outletEvening Standard
    Media typeWeb
    Country/TerritoryUnited Kingdom
    Date3/03/22
    DescriptionP

    eople who suffer from chronic cough may be offered new hope thanks to a drug that can ease the symptom.

    Researchers suggest the medication called gefapixant has the potential to have a significant impact on the lives of thousands of sufferers.

    Chronic coughing is defined as lasting more than eight weeks, and is thought to affect between 4% and 10% of the UK population, some of whom cough thousands a time a day over many years.
    URLhttps://www.standard.co.uk/news/uk/people-warrington-bbc-itv-b985978.html
    PersonsJacky Smith

Keywords

  • chronic cough
  • medicine